PHOREMOST LTD has a total of 24 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2014. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are SHANDONG LVDU BIO SICIENCE & TECH CO LTD, GENTIUM S R L and CEMM FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | China | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Computational chemistry | |
#6 | Bioinformatics | |
#7 | Therapeutic chemical compounds | |
#8 | Peptides | |
#9 | Combinatorial chemistry | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Mckenzie Grahame James | 6 |
#2 | Muellner Markus | 4 |
#3 | Hardwick Bryn Shaun | 4 |
#4 | Torrance Chris | 3 |
#5 | Germano Giovanni | 3 |
#6 | Bardelli Alberto | 3 |
#7 | Yarker Joanne L | 2 |
#8 | Howes Jennifer | 1 |
#9 | De La Gándara Alberto Moreno | 1 |
#10 | Moreno Alberto | 1 |
Publication | Filing date | Title |
---|---|---|
GB201906705D0 | Methods | |
GB201904765D0 | Target for anti-cancer therapy | |
GB201901817D0 | Methods | |
GB201819721D0 | Target for anti-cancer therapy | |
GB201816825D0 | Target for anti-cancer therapy | |
GB201816440D0 | Nucleic acid libraries, peptide libraries and uses thereof | |
GB201717034D0 | Targets for anti-cancer therapy | |
GB201709916D0 | Nucleic acid libraries, peptide libraries and uses thereof | |
EP3445345A2 | Inactivation of dna repair as an anticancer therapy | |
GB201602871D0 | Pharmaceutical compounds | |
GB201602861D0 | Pharmaceutical compounds | |
GB201522618D0 | Methods of screening | |
GB201413451D0 | Novel compounds |